Trails Edge Capital Partners, LP
Source: SEC Form 13F · as of Mar 2026Trails Edge Capital Partners, LP holds 17 biotech & pharma companies tracked by BioSniper, totaling $308.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$308.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Vaxcyte, Inc. (PCVX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PCVXVaxcyte, Inc. | 662,470 | $38.5M |
| DFTXDefinium Therapeutics Inc. | 1,738,110 | $32.9M |
| LBRXLB PHARMACEUTICALS INC | 1,319,362 | $32.5M |
| NRIXNurix Therapeutics, Inc. | 1,743,220 | $27.0M |
| RVMDREVOLUTION MEDICINES, INC. | 245,000 | $23.8M |
| RCUSArcus Biosciences, Inc. | 1,047,935 | $22.6M |
| IMCRImmunocore Holdings plc | 682,597 | $20.6M |
| CYTKCYTOKINETICS INC | 300,000 | $19.8M |
| NGNENeurogene Inc. | 782,787 | $15.8M |
| IVAInventiva S.A. | 2,657,997 | $14.8M |
| FDMT4D Molecular Therapeutics, Inc. | 1,302,917 | $12.1M |
| XFORX4 Pharmaceuticals, Inc | 2,571,478 | $10.6M |
| IMVTImmunovant, Inc. | 414,054 | $10.3M |
| DSGNDesign Therapeutics, Inc. | 852,013 | $9.1M |
| CAMPCamp4 Therapeutics Corp | 1,939,563 | $8.6M |
| PMNProMIS Neurosciences Inc. | 557,103 | $7.1M |
| IRDOpus Genetics, Inc. | 500,000 | $2.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.